Ebola treatment trial completed
- 22 June 2015
An Oxford University led study into the effectiveness of a potential Ebola treatment, called TKM-Ebola-Guinea, is no longer recruiting patients after reaching a pre-defined endpoint.
Image courtesy of Shutterstock
Early results indicated that continued enrolment to the study, which has been running since March 2015 in Sierra Leone, was unlikely to demonstrate an overall therapeutic benefit to patients.
The research team is currently analysing the data collected during the trial and will make the results available as soon as possible. The single-arm phase II study (RAPIDE-TKM), is led by Professor Peter Horby of the University of Oxford on behalf of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) in collaboration with the College of Medicine and Allied Health Sciences in Sierra Leone. The study is funded by the Wellcome Trust.